• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p53 修饰:强大守护者的精致装饰。

p53 modifications: exquisite decorations of the powerful guardian.

机构信息

Institute for Cancer Genetics, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.

Department of Pathology and Cell Biology, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.

出版信息

J Mol Cell Biol. 2019 Jul 19;11(7):564-577. doi: 10.1093/jmcb/mjz060.

DOI:10.1093/jmcb/mjz060
PMID:31282934
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6736412/
Abstract

The last 40 years have witnessed how p53 rose from a viral binding protein to a central factor in both stress responses and tumor suppression. The exquisite regulation of p53 functions is of vital importance for cell fate decisions. Among the multiple layers of mechanisms controlling p53 function, posttranslational modifications (PTMs) represent an efficient and precise way. Major p53 PTMs include phosphorylation, ubiquitination, acetylation, and methylation. Meanwhile, other PTMs like sumoylation, neddylation, O-GlcNAcylation, adenosine diphosphate (ADP)-ribosylation, hydroxylation, and β-hydroxybutyrylation are also shown to play various roles in p53 regulation. By independent action or interaction, PTMs affect p53 stability, conformation, localization, and binding partners. Deregulation of the PTM-related pathway is among the major causes of p53-associated developmental disorders or diseases, especially in cancers. This review focuses on the roles of different p53 modification types and shows how these modifications are orchestrated to produce various outcomes by modulating p53 activities or targeted to treat different diseases caused by p53 dysregulation.

摘要

过去的 40 年见证了 p53 如何从一种病毒结合蛋白上升为应激反应和肿瘤抑制的核心因素。p53 功能的精细调节对于细胞命运决策至关重要。在控制 p53 功能的多种机制中,翻译后修饰 (PTM) 是一种有效且精确的方式。p53 的主要 PTM 包括磷酸化、泛素化、乙酰化和甲基化。同时,其他 PTM,如 SUMOylation、NEDDylation、O-GlcNAcylation、二磷酸腺苷 (ADP)-核糖基化、羟基化和 β-羟基丁酰化,也被证明在 p53 调节中发挥各种作用。通过独立作用或相互作用,PTM 影响 p53 的稳定性、构象、定位和结合伙伴。PTM 相关途径的失调是 p53 相关发育障碍或疾病(尤其是癌症)的主要原因之一。本综述重点介绍了不同 p53 修饰类型的作用,并展示了这些修饰如何通过调节 p53 活性或针对由 p53 失调引起的不同疾病进行靶向治疗来协调产生各种结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b474/6736412/b6927ab541e4/mjz060f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b474/6736412/2b82124f2109/mjz060f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b474/6736412/ea769d77e7bc/mjz060f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b474/6736412/30bb1c65277c/mjz060f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b474/6736412/b6927ab541e4/mjz060f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b474/6736412/2b82124f2109/mjz060f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b474/6736412/ea769d77e7bc/mjz060f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b474/6736412/30bb1c65277c/mjz060f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b474/6736412/b6927ab541e4/mjz060f4.jpg

相似文献

1
p53 modifications: exquisite decorations of the powerful guardian.p53 修饰:强大守护者的精致装饰。
J Mol Cell Biol. 2019 Jul 19;11(7):564-577. doi: 10.1093/jmcb/mjz060.
2
p53 post-translational modification: deregulated in tumorigenesis.p53 翻译为“p53 蛋白”;post-translational modification 翻译为“翻译后修饰”;tumorgenesis 翻译为“肿瘤发生”。 因此,这句话的译文为: p53 蛋白翻译后修饰:肿瘤发生中失调。
Trends Mol Med. 2010 Nov;16(11):528-36. doi: 10.1016/j.molmed.2010.09.002.
3
Surf the post-translational modification network of p53 regulation.探索 p53 调控的翻译后修饰网络。
Int J Biol Sci. 2012;8(5):672-84. doi: 10.7150/ijbs.4283. Epub 2012 May 10.
4
Post-translational modifications of p53 tumor suppressor: determinants of its functional targets.p53 肿瘤抑制因子的翻译后修饰:其功能靶点的决定因素。
Histol Histopathol. 2012 Apr;27(4):437-43. doi: 10.14670/HH-27.437.
5
Crosstalk between Ubiquitination and Other Post-translational Protein Modifications in Plant Immunity.泛素化与植物免疫中其他翻译后蛋白修饰的相互作用。
Plant Commun. 2020 Mar 25;1(4):100041. doi: 10.1016/j.xplc.2020.100041. eCollection 2020 Jul 13.
6
Regulating tumor suppressor genes: post-translational modifications.调控肿瘤抑制基因:翻译后修饰。
Signal Transduct Target Ther. 2020 Jun 10;5(1):90. doi: 10.1038/s41392-020-0196-9.
7
Dissecting roles of ubiquitination in the p53 pathway.剖析泛素化在p53信号通路中的作用。
Ernst Schering Found Symp Proc. 2008(1):127-36. doi: 10.1007/2789_2008_105.
8
Functional analysis of the roles of posttranslational modifications at the p53 C terminus in regulating p53 stability and activity.p53 蛋白 C 末端翻译后修饰在调节 p53 稳定性和活性中的作用的功能分析
Mol Cell Biol. 2005 Jul;25(13):5389-95. doi: 10.1128/MCB.25.13.5389-5395.2005.
9
Deciphering the PTM codes of the tumor suppressor p53.解析肿瘤抑制因子 p53 的 PTM 密码。
J Mol Cell Biol. 2022 Jan 21;13(11):774-785. doi: 10.1093/jmcb/mjab047.
10
The regulation of radiosensitivity by p53 and its acetylation.p53 及其乙酰化对放射敏感性的调节。
Cancer Lett. 2015 Jul 28;363(2):108-18. doi: 10.1016/j.canlet.2015.04.015. Epub 2015 Apr 21.

引用本文的文献

1
Mechanistic Insights into the Anti-Hepatocellular Carcinoma Effects of ACY-1215: p53 Acetylation and Ubiquitination Regulation.ACY-1215抗肝细胞癌作用的机制性见解:p53乙酰化和泛素化调控
Curr Issues Mol Biol. 2025 May 8;47(5):338. doi: 10.3390/cimb47050338.
2
Tubulin Acetylation: A Critical Regulator of Microtubule Function.微管蛋白乙酰化:微管功能的关键调节因子
Results Probl Cell Differ. 2025;75:91-140. doi: 10.1007/978-3-031-91459-1_4.
3
The PURB-HOTAIR complex regulates p53-dependent promoter-specific transcriptional activation.

本文引用的文献

1
SMYD3 promotes epithelial ovarian cancer metastasis by downregulating p53 protein stability and promoting p53 ubiquitination.SMYD3 通过下调 p53 蛋白稳定性并促进 p53 泛素化来促进卵巢上皮性癌细胞转移。
Carcinogenesis. 2019 Dec 31;40(12):1492-1503. doi: 10.1093/carcin/bgz078.
2
Pellino1 specifically binds to phospho-Thr18 of p53 and is recruited to sites of DNA damage.Pellino1 特异性结合磷酸化 p53 的 Thr18 并募集到 DNA 损伤部位。
Biochem Biophys Res Commun. 2019 Jun 4;513(3):714-720. doi: 10.1016/j.bbrc.2019.03.095. Epub 2019 Apr 12.
3
RBCK1 promotes p53 degradation via ubiquitination in renal cell carcinoma.
PURB-HOTAIR复合物调节p53依赖的启动子特异性转录激活。
Nat Struct Mol Biol. 2025 Jun 25. doi: 10.1038/s41594-025-01597-3.
4
A Tailored Phospho-p53 Library Probes Antibody Specificity and Recognition Limitations.一个定制的磷酸化p53文库探究抗体特异性和识别局限性。
Chembiochem. 2025 Jul 18;26(14):e202500256. doi: 10.1002/cbic.202500256. Epub 2025 Jun 23.
5
Defining the transcriptional routes controlling lncRNA NEAT1 expression: implications in cellular stress response, inflammation, and differentiation.定义控制长链非编码RNA NEAT1表达的转录途径:对细胞应激反应、炎症和分化的影响
Discov Oncol. 2025 May 15;16(1):768. doi: 10.1007/s12672-025-02510-6.
6
High-Frequency Mutations in TP53, AXIN1, CTNNB1, and KRAS, and Polymorphisms in JAK1 Genes Among Mongolian HCC Patients.蒙古族肝癌患者中TP53、AXIN1、CTNNB1和KRAS基因的高频突变以及JAK1基因的多态性
Cancer Rep (Hoboken). 2025 May;8(5):e70227. doi: 10.1002/cnr2.70227.
7
RSK2 and its binding partners: an emerging signaling node in cancers.核糖体S6激酶2(RSK2)及其结合伴侣:癌症中一个新出现的信号节点
Arch Pharm Res. 2025 May;48(5):365-383. doi: 10.1007/s12272-025-01543-3. Epub 2025 May 5.
8
AIG1 protects against doxorubicin-induced cardiomyocyte ferroptosis and cardiotoxicity by promoting ubiquitination-mediated p53 degradation.AIG1通过促进泛素化介导的p53降解来保护细胞免受阿霉素诱导的心肌细胞铁死亡和心脏毒性。
Theranostics. 2025 Mar 31;15(11):4931-4954. doi: 10.7150/thno.108410. eCollection 2025.
9
Possible impacts of cosmic radiation on leukemia development during human deep space exploration.宇宙辐射对人类深空探索期间白血病发生的潜在影响。
Leukemia. 2025 Apr 24. doi: 10.1038/s41375-025-02624-4.
10
Pyrimidine synthase CAD deamidates and inactivates p53.嘧啶合成酶CAD使p53脱酰胺并使其失活。
Cell Res. 2025 Jul;35(7):520-523. doi: 10.1038/s41422-025-01112-9. Epub 2025 Apr 17.
RBCK1 通过泛素化促进肾细胞癌中的 p53 降解。
Cell Death Dis. 2019 Mar 15;10(4):254. doi: 10.1038/s41419-019-1488-2.
4
p53 β-hydroxybutyrylation attenuates p53 activity.p53 的 β-羟基丁酰化会削弱其活性。
Cell Death Dis. 2019 Mar 11;10(3):243. doi: 10.1038/s41419-019-1463-y.
5
TRIM69 inhibits cataractogenesis by negatively regulating p53.TRIM69 通过负向调控 p53 抑制白内障形成。
Redox Biol. 2019 Apr;22:101157. doi: 10.1016/j.redox.2019.101157. Epub 2019 Mar 2.
6
The multiple mechanisms that regulate p53 activity and cell fate.调控 p53 活性和细胞命运的多种机制。
Nat Rev Mol Cell Biol. 2019 Apr;20(4):199-210. doi: 10.1038/s41580-019-0110-x.
7
Adeno-associated virus vector as a platform for gene therapy delivery.腺相关病毒载体作为基因治疗传递的平台。
Nat Rev Drug Discov. 2019 May;18(5):358-378. doi: 10.1038/s41573-019-0012-9.
8
CRISPR-Cas: a tool for cancer research and therapeutics.CRISPR-Cas:癌症研究与治疗的工具。
Nat Rev Clin Oncol. 2019 May;16(5):281-295. doi: 10.1038/s41571-019-0166-8.
9
IKKβ activates p53 to promote cancer cell adaptation to glutamine deprivation.IKKβ激活p53以促进癌细胞适应谷氨酰胺剥夺。
Oncogenesis. 2018 Nov 26;7(11):93. doi: 10.1038/s41389-018-0104-0.
10
Functions and mechanisms of non-histone protein acetylation.非组蛋白蛋白乙酰化的功能和机制。
Nat Rev Mol Cell Biol. 2019 Mar;20(3):156-174. doi: 10.1038/s41580-018-0081-3.